EFNB2 and neoplasm: Interference with this pathway using EphB4 kinase inhibition or genetic depletion of endothelial Ephrin-B2 resulted in increased dissemination of tumor cells, diverse metastatic loci in the spine, and an early onset of locomotion deficits [10].